Russell Investments »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Russell Investments

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Russell Investments from 13F filings

Historical chart of Russell Investments investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Russell Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Russell Investments

Quarter filed Position value Share count Share price at filing
2024-03-31 $509k 541k 0.94
2023-12-31 $47k 47k 0.99

More positions owned by Russell Investments

Microsoft Corp Common Stock (MSFT)
Nvidia Corp Common Stock (NVDA)
Apple Common Stock (AAPL)
Amazon Common Stock (AMZN)
Meta Platforms Common Stock (META)
Alphabet Common Stock (GOOGL)
Alphabet Common Stock (GOOG)
Taiwan Semiconductor Manufacturing Common Stock (TSM)
Mastercard Incorporated Common Stock (MA)
Prologis Common Stock (PLD)
Unitedhealth Group Common Stock (UNH)
Eli Lilly And Company Common Stock (LLY)
Equinix Common Stock (EQIX)
Welltower Common Stock (WELL)
Visa Common Stock (V)

View all positions for Russell Investments

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ubs Global Asset Management Americas
Readystate Asset Management
Steelhead Partners
Calamos Advisors
Aequim Alternative Investments
Davidson Kempner Capital Management
Wolverine Asset Management
Lazard Asset Management
Zazove Associates
Shenkman Capital Management
CNH Partners
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main
Capstone Investment Advisors
Citadel Advisors
MacKay Shields

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1